Sensei Biotherapeutics Inc (NASDAQ:SNSE) — Market Cap & Net Worth
Market Cap & Net Worth: Sensei Biotherapeutics Inc (SNSE)
Sensei Biotherapeutics Inc (NASDAQ:SNSE) has a market capitalization of $19.50 Million ($19.50 Million) as of June 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #25218 globally and #5281 in its home market, demonstrating a 11.77% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sensei Biotherapeutics Inc's stock price $14.53 by its total outstanding shares 1341941 (1.34 Million). Review Sensei Biotherapeutics Inc total liabilities to assess the company's total debt and financial obligations.
Sensei Biotherapeutics Inc Market Cap History: 2021 to 2026
Sensei Biotherapeutics Inc's market capitalization history from 2021 to 2026. Data shows change from $7.78 Million to $19.50 Million (-4.78% CAGR).
Index Memberships
Sensei Biotherapeutics Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.43 Trillion | 0.00% | #720 of 976 |
|
NASDAQ Composite
IXIC
|
$41.27 Trillion | 0.00% | #2362 of 3165 |
Weight: Sensei Biotherapeutics Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Sensei Biotherapeutics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sensei Biotherapeutics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SNSE by Market Capitalization
Companies near Sensei Biotherapeutics Inc in the global market cap rankings as of June 17, 2026.
Key companies related to Sensei Biotherapeutics Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #442 globally with a market cap of $63.33 Billion USD.
- UCB SA (BR:UCB): Ranked #550 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #574 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $453.17 |
| #442 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $63.33 Billion | $614.73 |
| #550 | UCB SA | BR:UCB | $49.68 Billion | €250.00 |
| #574 | Argen-X | BR:ARGX | $47.14 Billion | €755.80 |
Sensei Biotherapeutics Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, Sensei Biotherapeutics Inc's market cap moved from $7.78 Million to $ 19.50 Million, with a yearly change of -4.78%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $19.50 Million | +36.18% |
| 2025 | $14.32 Million | +2077.11% |
| 2024 | $657.69K | -29.18% |
| 2023 | $928.62K | -53.56% |
| 2022 | $2.00 Million | -74.31% |
| 2021 | $7.78 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Sensei Biotherapeutics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $19.50 Million USD |
| MoneyControl | $19.50 Million USD |
| MarketWatch | $19.50 Million USD |
| marketcap.company | $19.50 Million USD |
| Reuters | $19.50 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sensei Biotherapeutics Inc
Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune … Read more